Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
59.72
-0.44 (-0.73%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Inspire Medical Systems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 127.76 | 104.81 | 150.15 | 185.54 | 441.59 | 214.47 |
Short-Term Investments | 192.92 | 203.46 | 295.4 | 274.84 | 9.82 | - |
Cash & Short-Term Investments | 320.68 | 308.27 | 445.55 | 460.38 | 451.41 | 214.47 |
Cash Growth | 6.58% | -30.81% | -3.22% | 1.98% | 110.48% | -8.49% |
Accounts Receivable | 103.34 | - | - | 89.88 | 61.23 | 34.18 |
Inventory | 170.45 | 145.29 | 80.12 | 33.89 | 11.89 | 17.23 |
Other Current Assets | 14.2 | 10.4 | 12.07 | 9.6 | 5.51 | 2.66 |
Total Current Assets | 608.67 | 583.65 | 630.81 | 593.74 | 530.03 | 268.54 |
Net Property, Plant & Equipment | 126.93 | 121.4 | 95.24 | 62.65 | 24.13 | 16.41 |
Long-Term Investments | 94.48 | 96.33 | 71 | 9.14 | - | 9.94 |
Other Long-Term Assets | 95.91 | 105.93 | 11.34 | 11.28 | 10.72 | 0.2 |
Total Assets | 925.99 | 907.32 | 808.38 | 676.81 | 564.88 | 295.08 |
Accounts Payable | - | - | - | 38.84 | 26.85 | 11.67 |
Accrued Expenses | - | - | - | 39.27 | 34.34 | 20.45 |
Current Portion of Long-Term Debt | - | - | - | - | - | 9.19 |
Total Current Liabilities | 71.18 | 96.06 | 88.5 | 78.11 | 61.19 | 41.31 |
Long-Term Debt | - | - | - | - | - | 15.8 |
Long-Term Leases | 29.09 | 30 | 30.04 | 24.85 | 7.54 | 8.8 |
Other Long-Term Liabilities | 0.14 | 0.1 | 0.15 | 1.35 | 0.15 | 0.13 |
Total Long-Term Liabilities | 29.23 | 30.1 | 30.19 | 26.19 | 7.68 | 24.73 |
Total Liabilities | 100.41 | 126.16 | 118.69 | 104.3 | 68.87 | 66.04 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Additional Paid-in Capital | 983.67 | 927.16 | 981.04 | 917.11 | 820.34 | 508.47 |
Accumulated Other Comprehensive Income | -0.65 | 0.46 | 0.54 | 0.8 | -0.09 | -0.06 |
Retained Earnings | -157.47 | -146.49 | -291.91 | -345.42 | -324.27 | -279.39 |
Shareholders' Equity | 825.58 | 781.16 | 689.7 | 572.51 | 496.01 | 229.05 |
Total Liabilities & Equity | 925.99 | 907.32 | 808.38 | 676.81 | 564.88 | 295.08 |
Total Debt | 29.09 | 30 | 30.04 | 24.85 | 7.54 | 33.78 |
Net Cash (Debt) | 291.59 | 278.27 | 415.51 | 435.53 | 443.88 | 180.68 |
Net Cash Growth | 8.00% | -33.03% | -4.60% | -1.88% | 145.66% | -11.31% |
Net Cash Per Share | 10.02 | 9.35 | 13.60 | 14.86 | 15.81 | 6.63 |
Book Value | 825.58 | 781.16 | 689.7 | 572.51 | 496.01 | 229.05 |
Book Value Per Share | 28.36 | 26.25 | 22.58 | 19.54 | 17.67 | 8.40 |
Tangible Book Value | 825.58 | 781.16 | 689.7 | 572.51 | 496.01 | 229.05 |
Tangible Book Value Per Share | 28.36 | 26.25 | 22.58 | 19.54 | 17.67 | 8.40 |